Blood test for assessing lung cancer risk in vulnerable populations, including those with age or smoking history risk factors, enabling early detection and intervention.
Manufactured by
Ease Healthcare
United States
Ease Healthcare (a registered DBA of MPS Medical, Inc.) empowers proactive health management with advanced diagnostic tools, monitoring devices, and innovative wellness technologies. The company licenses and distributes products across three key categories: traditional lateral flow test kits for rapid detection of COVID-19, Flu A and B, HPV, and other conditions including women's health and drug testing; FDA-approved consumer medical devices branded under Ease Healthcare, including blood pressure monitors, pulse oximeters, and thermometers; and innovative screening and diagnostic tests such as lung cancer screening tests, approved for sale in the U.S. and globally. Ease Healthcare operates a state-of-the-art, FDA-registered facility in Brea, California, spanning 30,000 square feet, featuring a 3,200-square-foot ISO Class 8 clean room with precise temperature and humidity controls for medical device production and an 18,000-square-foot warehouse with multizone temperature monitoring. The company also provides manufacturing and third-party logistics (3PL) services to other medical device companies.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 4 relevant products
FUJIFILM Healthcare Americas Corporation
United States · 3 relevant products
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 80 closest product alternatives
BioChain (Beijing) Science & Technology. Inc. · China
Advanced early detection test for lung cancer screening utilizing molecular diagnostic technology. This in-development product represents the company's expansion into early detection for pulmonary malignancies. The test is designed for high-risk population screening and clinical intervention.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
FUJIFILM Healthcare Americas Corporation · United States
Comprehensive in vitro diagnostic test system for hepatocellular carcinoma risk assessment in patients with chronic liver disease. Integrates AFP-L3 and DCP biomarker testing for improved early detection.
77 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products